Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

6505--Mesalamine 1200mg Tablet (VA-27-00000768)

Awarded
36E79726R0025Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The solicitation 36E79726R0025 seeks offers for Mesalamine 1200mg Tablet under the Pharmaceutical Prime Vendor program administered by the Department of Veterans Affairs, with procurement activities centered in Hines, IL. The contract is structured as a five-year arrangement with one base year and four one-year option periods, all subject to unilateral government exercise. The primary requirement is the supply of 120-tablet bottles of enteric-coated delayed-release mesalamine, with identical quantities specified for each year. Pricing must include a 0.5% Cost Recovery Fee and must not exceed the Federal Ceiling Price plus this fee for drugs governed by 38 U.S.C. § 8126(h)(2); all prices must be submitted to two decimal places and cover the full term, including all option years. Offerors must be registered in SAM with an active Unique Entity Identifier, DUNS number, and Tax ID, and must submit a signed SF-1449 via email along with supporting documentation in Word or PDF format, excluding faxes, zip files, or folders. Distributors must provide a manufacturer's Letter of Commitment guaranteeing supply continuity, and manufacturers must remain unchanged throughout the contract term. All products require unit-of-use packaging with a cylindrical bottle of at least 5.75” circumference and 120cc volume, a safety or convertible cap not exceeding the bottle diameter, no glass materials, and a 5.25” x 2” label with an additional 0.5” buffer for expiration date, lot number, and bar code exposure. VA labels must adhere securely over the contractor’s label. Every unit must carry a bar code in GS1-128, HIBC, or UPC format encoding the NDC, printed at ANSI/ISO/IEC Grade C or better, verified prior to shipment, and present on both immediate and outer packaging. Products must be compatible with automated dispensing systems like Optifill and Baxter ATC Canisters. Contract performance is governed by delivery through Government Prime Vendor programs, with payments made by those vendors, not directly by the government, and no assignment of payment rights is permitted. Offerors must maintain a business-to-business agreement with the PPV programs. Subcontracting requirements include a Small Business Subcontracting Plan for non-small businesses, reporting via eSRS for small, veteran-owned, HUBZone, women-owned, and disadvantaged businesses, and inclusion of

General Info

VA seeks one supplier for Mesalamine 1200mg tablets, one-year base plus four options, delivery via VA/DoD vendors.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

4

Amendment 0001 to Solicitation 36E79726R0025 - Proposal Due Date Extension

DOCX, High priority: read this firstamendment
High

RFP 36E79726R0025 Mesalamine 1200mg Tablet

DOCX, High priority: read this first3 pages · presolicitation
High

Solicitation 36E79726R0025 for Mesalamine 1200MG Tablets

DOCX, High priority: read this firstrfq
High

Award 36E79726D0043 - Mesalamine 1200mg Tablet

DOCX, Low priority3 pages · award
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

Response deadline changed from Jun 9, 2026 to Jun 18, 2026. The notice description changed.

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Youlanda DuggarContract Specialist

Full Description

Show more
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0025 for an unrestricted procurement for Mesalamine 1200MG (1.2GM) Tablets Enteric Coated (EC) Delayed Release (DR) (Unit of Use), 120 Tablets per Bottle, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line item 1 120 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0025 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 25, 2026 with a tentative closing date of June 9, 2026 The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to contact@example.gov. The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) Mesalamine 1200MG (1.2GM) Tablets Enteric Coated (EC) Delayed Release (DR) (Unit of Use), 120 107,364

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

6 days ago

DEADLINE

in 6 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 2 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS